Exact Sciences Corporation - Common Stock (NQ:EXAS)

103.18 +0.52 (+0.51%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist

Price and Volume

Volume	4,754,737
Open	102.75
Bid (Size)	101.81 (200)
Ask (Size)	103.50 (100)
Prev. Close	102.66
Today's Range	102.34 - 103.42
52wk Range	38.81 - 102.73
Shares Outstanding	171,948,769
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Era of the Titans: Q4 2025 Mega-Deal Surge and the 2026 Economic Map

Today 10:17 EST

As of February 6, 2026, the global financial landscape is still reverberating from a historic tectonic shift that occurred in the final months of last year. In the fourth quarter of 2025, the M&A...

Via MarketMinute

1 Growth Stock to Stash and 2 We Avoid

February 05, 2026

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who...

Via StockStory

Performance

YTD	+1.4%	+1.4%
1 Month	+1.5%	+1.5%
3 Month	+53.5%	+53.5%
6 Month	+139.1%	+139.1%
1 Year	+85.0%	+85.0%

More News

Halper Sadeh LLC is Investigating SKYT, EXAS, GORO, MOVE on Behalf of Shareholders

February 03, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests

February 03, 2026

From Exact Sciences Corp.

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (Nasdaq - NFBK), Coterra Energy Inc. (NYSE - CTRA), Exact Sciences Corporation (Nasdaq – EXAS), Semrush Holdings, Inc. (NYSE – SEMR)

February 03, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide

February 03, 2026

From Exact Sciences Corp.

Via Business Wire

Halper Sadeh LLC Reminds Shareholders of EXAS, DVN, NFBK of the Firm’s Investigations

February 02, 2026

From Halper Sadeh LLC

Via GlobeNewswire

The Best Dividend King to Buy With $150 ↗

February 02, 2026

Via The Motley Fool

Boston Scientific’s $14.5 Billion Stroke of Genius: Consolidation Heats Up in the Medtech Arms Race

February 02, 2026

Via MarketMinute

3 Reasons to Buy This Dividend King After Its Steep Sell-Off ↗

January 26, 2026

Via The Motley Fool

Abbott Laboratories Shares Plunge 10% Following Q4 Revenue Miss and Diagnostics Weakness

January 22, 2026

Via MarketMinute

Abbott Shares Slump as Revenue Miss and Exact Sciences Acquisition Jitters Overshadow Earnings Beat

January 22, 2026

Via MarketMinute

Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights

January 21, 2026

From Halper Sadeh LLC

Via GlobeNewswire

$5.1 Trillion Global Surge: CEO Confidence Ignites New Era of M&A Transformation

January 19, 2026

Via MarketMinute

Halper Sadeh LLC Encourages SEE, EXAS, ZEUS Shareholders to Contact the Firm to Discuss Their Rights

January 17, 2026

From Halper Sadeh LLC

Via GlobeNewswire

CS Diagnostics (OTCQB: CSDX) Advances Infection Control and Oncology Innovation Plus – IVP, SAFX, JTAI, OCG, BMXI Inside

January 14, 2026

Via AB Newswire

The Great Diagnostic Consolidation: How a $25.7 Billion Mega-Deal Ignited a 150% Surge in Healthcare M&A

January 14, 2026

Via MarketMinute

GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth

January 13, 2026

Via MarketMinute

Adaptive Biotechnologies Surges as Preliminary 2025 Results Signal a Turning Point in MRD Commercialization

January 13, 2026

Via MarketMinute

Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability

January 12, 2026

Via MarketMinute

Halper Sadeh LLC Encourages EXAS, FRGE, TBHC, FFWM Shareholders to Contact the Firm to Discuss Their Rights

January 09, 2026

From Halper Sadeh LLC

Via GlobeNewswire

3 Mid-Cap Stocks We Steer Clear Of

January 08, 2026

Via StockStory

Stay updated with the stocks that are on the move in today's after-hours session. ↗

January 07, 2026

Via Chartmill

1 High-Flying Stock on Our Watchlist and 2 We Question

January 04, 2026

Via StockStory

3 Unpopular Stocks We Steer Clear Of

December 30, 2025

Via StockStory

Frequently Asked Questions

Is Exact Sciences Corporation - Common Stock publicly traded?

Yes, Exact Sciences Corporation - Common Stock is publicly traded.

What exchange does Exact Sciences Corporation - Common Stock trade on?

Exact Sciences Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Exact Sciences Corporation - Common Stock?

The ticker symbol for Exact Sciences Corporation - Common Stock is EXAS on the Nasdaq Stock Market

What is the current price of Exact Sciences Corporation - Common Stock?

The current price of Exact Sciences Corporation - Common Stock is 103.18

When was Exact Sciences Corporation - Common Stock last traded?

The last trade of Exact Sciences Corporation - Common Stock was at 02/06/26 04:00 PM ET

What is the market capitalization of Exact Sciences Corporation - Common Stock?

The market capitalization of Exact Sciences Corporation - Common Stock is 17.74B

How many shares of Exact Sciences Corporation - Common Stock are outstanding?

Exact Sciences Corporation - Common Stock has 18B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.